The 6-Kilodalton Early Secreted Antigenic Target-Responsive, Asymptomatic Contacts of Tuberculosis Patients Express Elevated Levels of Interleukin-4 and Reduced Levels of Gamma Interferon
- 1 May 2006
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 74 (5) , 2817-22
- https://doi.org/10.1128/iai.74.5.2817-2822.2006
Abstract
It is well known that the majority of healthy individuals exposed toMycobacterium tuberculosisdo not become clinically ill. We have previously shown that in recently exposed healthy contacts of tuberculosis (TB) patients, a strong immune response to theM. tuberculosis6-kDa early secreted antigenic target (ESAT-6) virulence factor correlated with a higher risk of subsequent disease, although the mechanism was unclear at that time. Inspired by recent reports that elevated expression of interleukin-4 (IL-4) in health care workers exposed toM. tuberculosisalso correlated with a higher risk of their subsequently developing disease, we examined expression of IL-4, its competitive antagonist IL-4δ2, and gamma interferon (IFN-γ) in healthy household contacts of TB patients from Ethiopia. We then compared cytokine expression to their recognition of ESAT-6 (which is largely restricted to members of the tuberculosis complex and which serves as a reliable marker of infection) or to Ag85A (an antigen that is conserved among the mycobacteria and serves as a nonspecific control). Our study shows that in these recently exposed individuals, there is a correlation between a strong response to ESAT-6 and elevated expression of IL-4. Further, elevated expression of IL-4 is associated with lower expression of its antagonistic splice variant IL-4δ2 and with the Th1 cytokine IFN-γ, suggesting that in these at-risk individuals, immunity is skewed away from a protective Th1 response, even before the development of clinical symptoms.Keywords
This publication has 39 references indexed in Scilit:
- Quantitative T Cell Assay Reflects Infectious Load of Mycobacterium tuberculosis in an Endemic Case Contact ModelClinical Infectious Diseases, 2005
- Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6Vaccine, 2004
- Increased expression of mRNA encoding interleukin (IL)‐4 and its splice variant IL‐4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulationImmunology, 2004
- Correlates of protective immune response in tuberculous pleuritisFEMS Immunology & Medical Microbiology, 2004
- Intracellular expression of interleukin‐4 and interferon‐γ by a Mycobacterium tuberculosis antigen‐stimulated CD4+ CD57+ T‐cell subpopulation with memory phenotype in tuberculosis patientsImmunology, 2003
- Epidemiology of tuberculosisSeminars in Respiratory Infections, 2003
- Helicobacter pylori cagPathogenicity Island Is Associated with Reduced Expression of Interleukin-4 (IL-4) mRNA and Modulation of the IL-4δ2 mRNA Isoform in Human Gastric MucosaInfection and Immunity, 2003
- Long‐Lived Immune Response to Early Secretory Antigenic Target 6 in Individuals Who Had Recovered from TuberculosisClinical Infectious Diseases, 2001
- Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient PatientsScience, 1998
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.The Journal of Experimental Medicine, 1993